Midazolam (Surgical — Anxiolysis/Sedation)
Brand names: Hypnovel, Buccolam (buccal)
Midazolam is a short-acting intravenous benzodiazepine used surgically for premedication, conscious sedation for procedures, and the induction or maintenance of sedation in anaesthesia and critical care.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It potentiates the inhibitory neurotransmitter GABA at the GABA-A receptor, producing sedation, anxiolysis, anterograde amnesia and muscle relaxation.
Prescribing in practice
- Titrate slowly to effect with full resuscitation facilities and continuous monitoring, because midazolam causes dose-dependent respiratory depression and hypotension — risk is markedly increased by concomitant opioids and in the elderly, who need substantially reduced doses.
- Have the reversal agent flumazenil immediately available, and reduce dose in hepatic impairment, debilitated patients and where other CNS depressants are used.
- Allow adequate time for each increment to take effect before redosing, as delayed onset can lead to inadvertent oversedation.
Monitoring
Monitor respiratory rate, oxygen saturation, blood pressure and conscious/sedation level continuously throughout and during recovery.
Counselling the patient
- Explain it is a sedative given by injection to relax you, and that you may not remember parts of the procedure.
- Do not drive, operate machinery, drink alcohol or make important decisions for the rest of the day after sedation, and arrange for someone to accompany you home.
Evidence & guidelines
Midazolam is a standard agent for procedural sedation and anaesthetic premedication; UK safe-sedation guidance and the SPC stress titration, monitoring, dose reduction in the elderly and flumazenil availability.
Reference: MHRA Drug Safety Update 2016 (opioid + benzo); RCoA Regional Anaesthesia Guidelines; NICE NG180 (Sedation in Adults); MHRA SPC Hypnovel; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Richmond Agitation-Sedation Scale (RASS) · Sedation Assessment
- Confusion Assessment Method for ICU (CAM-ICU) · Delirium Assessment
- Ramsay Sedation Scale · Sedation
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- SORT (Surgical Outcome Risk Tool) · Perioperative Risk
- ASA Physical Status Classification · Perioperative Risk
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH